Cipher Pharmaceuticals Inc.
CPHRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$254M
Close$
$29.66
196.6% upside
Current Fair Value
196.6% upsideUndervalued by 196.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $254.00 Million |
|---|---|
| Enterprise Value | $257.78 Million |
| Earnings per Share | $1.09 |
| Beta | 0.48 |
| Outstanding Shares | 25,399,550 |
Return
| Return on Equity | 21.16% |
|---|---|
| Return on Assets | 18.51% |
| Return on Invested Capital | 13.93% |
Valuation & Multiples
| P/E Ratio | 8.39 |
|---|---|
| PEG | -24.96 |
| Price to Sales | 10.0 |
| Price to Book Ratio | 2.0 |
| Enterprise Value to Revenue | 5.23 |
| Enterprise Value to EBIT | 13.48 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
$0.42
Est. $0.20Revenue
$12.70 M
Est. $12.23 MNext Earnings Call
Expected Date
March 18, 2027
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$12.43 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cipher Pharmaceuticals, Inc.
5 employees
CEO: Craig Mull
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clin...